Explore
Validate
LearnABIN151100
antibody from antibodies-online
Targeting: NONO
NMT55, NRB54, P54, P54NRB, PPP1R114
Western blot Immunocytochemistry
Immunoprecipitation Immunohistochemistry
Chromatin ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [3]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN151100 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Non-POU Domain Containing, Octamer-Binding (NONO) (AA 350-400) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- AA 350-400
- Vial size
- 0.1 mL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Quantitative proteomics and dynamic imaging reveal that G3BP-mediated stress granule assembly is poly(ADP-ribose)-dependent following exposure to MNNG-induced DNA alkylation.
PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks.
TNF-alpha suppresses prolyl-4-hydroxylase alpha1 expression via the ASK1-JNK-NonO pathway.
Isabelle M, Gagné JP, Gallouzi IE, Poirier GG
Journal of cell science 2012 Oct 1;125(Pt 19):4555-66
Journal of cell science 2012 Oct 1;125(Pt 19):4555-66
PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks.
Krietsch J, Caron MC, Gagné JP, Ethier C, Vignard J, Vincent M, Rouleau M, Hendzel MJ, Poirier GG, Masson JY
Nucleic acids research 2012 Nov 1;40(20):10287-301
Nucleic acids research 2012 Nov 1;40(20):10287-301
TNF-alpha suppresses prolyl-4-hydroxylase alpha1 expression via the ASK1-JNK-NonO pathway.
Zhang C, Zhang MX, Shen YH, Burks JK, Zhang Y, Wang J, LeMaire SA, Yoshimura K, Aoki H, Coselli JS, Wang XL
Arteriosclerosis, thrombosis, and vascular biology 2007 Aug;27(8):1760-7
Arteriosclerosis, thrombosis, and vascular biology 2007 Aug;27(8):1760-7
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ICC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
